Search

Your search keyword '"Mansilha, Armando"' showing total 12 results
Start Over Author "Mansilha, Armando" Journal annals of vascular surgery
12 results on '"Mansilha, Armando"'

1. An International, Expert-Based Delphi Consensus Document on Controversial Issues about TransCarotid Artery Revascularization (TCAR)

Author

Paraskevas, Kosmas I., AbuRahma, Ali F., Abularrage, Christopher J., Clair, Daniel G., Eldrup-Jorgensen, Jens, Kashyap, Vikram S., Dardik, Alan, de Borst, Gert J., Dermody, Meghan, Faggioli, Gianluca, Hicks, Caitlin W., Kwolek, Christopher J., Lyden, Sean P., Mansilha, Armando, Van Herzeele, Isabelle, Myrcha, Piotr, Leal Lorenzo, Jose Ignacio, Jim, Jeffrey, Pini, Rodolfo, Secemsky, Eric A., Spinelli, Francesco, Capoccia, Laura, Stone, David H., Stoner, Michael C., Zeebregts, Clark J., Lal, Brajesh K., Schneider, Peter A., Malas, Mahmoud B., and Schermerhorn, Marc L.

Published
2025
Full Text
View/download PDF

7. Inflammation Is a Histological Characteristic of Skeletal Muscle in Chronic Limb Threatening Ischemia

Author

Ferreira, Joana, primary, Afonso, Julieta, additional, Longatto-Filho, Adhemar, additional, Roque, Susana, additional, Carneiro, Alexandre, additional, Vila, Isabel, additional, Silva, Cristina, additional, Cunha, Cristina, additional, Mesquita, Amílcar, additional, Cotter, Jorge, additional, Correia-Neves, Margarida, additional, Mansilha, Armando, additional, and Cunha, Pedro, additional

Published
2024
Full Text
View/download PDF

11. Association of Skeletal Muscle and Cardiovascular Risk Factors in Patients with Lower Extremity Arterial Disease

Author

Ferreira, Joana, Carneiro, Alexandre Lima, Vila, Isabel, Cunha, Cristina, Silva, C ristina, Longatto-Filho, Adhemar, Mesquita, Amesqui, Cotter, Jorge, Mansilha, Armando, Correia-Neves, Margarida, and Cunha, Pedro

Abstract

Sarcopenia is defined as low muscle mass, with low muscle strength or low physical performance. The skeletal muscle mass (or density) and strength are inversely associated with cardiovascular risk factors. We aim to determine the relationship between skeletal muscle characteristics (strength, mass, area), and cardiovascular risk factors in a population with lower extremity artery disease (LEAD).

Published
2021
Full Text
View/download PDF

12. An International, Expert-Based Delphi Consensus Document on Controversial Issues about TransCarotid Artery Revascularization (TCAR).

Author

Paraskevas KI, AbuRahma AF, Abularrage CJ, Clair DG, Eldrup-Jorgensen J, Kashyap VS, Dardik A, de Borst GJ, Dermody M, Faggioli G, Hicks CW, Kwolek CJ, Lyden SP, Mansilha A, Van Herzeele I, Myrcha P, Leal Lorenzo JI, Jim J, Pini R, Secemsky EA, Spinelli F, Capoccia L, Stone DH, Stoner MC, Zeebregts CJ, Lal BK, Schneider PA, Malas MB, and Schermerhorn ML

Abstract

Background: Transcarotid artery revascularization (TCAR) has emerged as an alternative therapeutic modality to carotid endarterectomy (CEA) and transfemoral carotid artery stenting (TFCAS) for the management of patients with carotid artery stenosis. However, certain issues regarding the indications and contraindications of TCAR remain unanswered or unresolved. The aim of this international, expert-based Delphi consensus document was to attempt to provide some guidance on these topics., Methods: A 3-round Delphi consensus process was performed, including 29 experts. The aim of round 1 was to investigate the differing views and opinions of the participants. Round 2 was carried out after the results from the literature on each topic were provided to the participants. During round 3, the participants had the opportunity to finalize their vote., Results: Most participants agreed that TCAR can or can probably or possibly be performed within 14 days of a cerebrovascular event, but it is best to avoid it in the first 48 hr. It was felt that TCAR cannot or should not replace TFCAS or CEA, as each procedure has specific indications and contraindications. Symptomatic patients >80 years should probably be treated with TCAR rather than with TFCAS. TCAR can or can probably be used for the treatment of restenosis following CEA or TFCAS. Finally, there is a need for a randomized controlled trial (RCT) to provide better evidence for the unresolved issues., Conclusions: This Delphi consensus document attempted to assist the decision-making of physicians or interventionalists or vascular surgeons involved in the management of carotid stenosis patients. Furthermore, areas requiring additional research were identified. Future studies and RCTs should provide more evidence to address the unanswered questions regarding TCAR., (Copyright © 2024 Elsevier Inc. All rights reserved.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results